Search of: "GW433908"[TREATMENT] AND HIV [CONDITION] - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 29 studies with search of:

"GW433908"[TREATMENT] AND HIV [CONDITION]

Hide studies that are not seeking new volunteers.

Display Options

1	Active, not recruiting	A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects
		Condition:	HIV Infection
		Interventions:	Drug: fosamprenavir (GW433908); Drug: ritonavir

2	Completed	KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
		Condition:	HIV Infection
		Interventions:	Drug: LEXIVA (GW433908); Drug: Ritonavir; Drug: KALETRA; Drug: EPIVIR; Drug: Ziagen; Drug: Abacavir/Lamivudine; Drug: Fosamprenavir

3	No longer available	Fosamprenavir Expanded Access
		Condition:	HIV Infection
		Interventions:	Drug: fosamprenavir; Drug: Telzir®

4	Recruiting	Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
		Condition:	HIV Infection
		Interventions:	Drug: GW433908; Drug: ritonavir

5	Active, not recruiting	Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
		Condition:	HIV Infections
		Interventions:	Drug: Lopinavir/Ritonavir; Drug: Ritonavir; Drug: GW433908

6	Recruiting	48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
		Condition:	HIV Infection
		Interventions:	Drug: LEXIVA (GW433908); Drug: Ritonavir

7	Active, not recruiting	Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
		Condition:	HIV Infections
		Interventions:	Drug: Abacavir sulfate; Drug: Nelfinavir mesylate; Drug: Lamivudine; Drug: GW433908

8	Active, not recruiting	Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
		Condition:	HIV Infections
		Interventions:	Drug: Ritonavir; Drug: Abacavir sulfate; Drug: Nelfinavir mesylate; Drug: Lamivudine; Drug: GW433908

9	Recruiting	A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
		Condition:	HIV Infections
		Interventions:	Drug: fosamprenavir; Drug: ritonavir

10	Completed	Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
		Condition:	HIV Infections
		Interventions:	Drug: fosamprenavir; Drug: COMBIVIR; Drug: ritonavir; Drug: TRIZIVIR

11	Completed	Fosamprenavir Versus Other Protease Inhibitors
		Condition:	HIV Infection
		Intervention:	Drug: fosamprenavir

12	Completed	Plasma Amprenavir In HIV-1-Infected Adult Subjects With Liver Function Impairment
		Conditions:	HIV Infection; Hepatic Impairment
		Interventions:	Drug: Fosamprenavir; Drug: Ritonavir

13	Completed	Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
		Condition:	HIV Infections
		Interventions:	Drug: Fosamprenavir; Drug: Lopinavir/Ritonavir; Drug: Ritonavir; Drug: Tenofovir disoproxil fumarate

14	Completed	Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
		Condition:	HIV Infection
		Intervention:	Drug: No intervention; Observational study

15	Active, not recruiting	"The Once A Day Protease Inhibitor Regimens"
		Conditions:	HIV Infections; Antiretroviral Therapy
		Interventions:	Drug: ritonavir-boosted atazanavir; Drug: ritonavir-boosted fosamprenavir

16	Completed	A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects
		Condition:	HIV Infection
		Interventions:	Drug: Fosamprenavir; Drug: ritonavir

17	Terminated	Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects
		Condition:	HIV-1
		Interventions:	Drug: fosamprenavir/ritonavir (700mg/100mg BID); Drug: fosamprenavir/ritonavir (1400mg/100mg BID); Drug: fosamprenavir/lopinavir/ritonavir (1400mg/533mg/100mg BID)

18	Recruiting	Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
		Condition:	HIV Infections
		Interventions:	Drug: Nevirapine; Drug: Efavirenz; Drug: Indinavir/ritonavir; Drug: Nelfinavir; Drug: Saquinavir/ritonavir; Drug: Lopinavir/ritonavir; Drug: Atazanavir; Drug: Atazanavir/ritonavir; Drug: Fos-amprenavir/ritonavir; Drug: Tipranavir/ ritonavir; Drug: Darunavir/ritonavir

19	Recruiting	Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
		Condition:	HIV Infections
		Interventions:	Drug: lopinavir; Drug: atazanavir; Drug: efavirenz; Drug: fosamprenavir; Drug: darunavir; Drug: tipranavir; Drug: ritonavir; Drug: nevirapine; Drug: zidovudine; Drug: lamivudine; Drug: tenofovir; Drug: emtricitabine; Drug: abacavir

20	Completed	Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients
		Condition:	HIV Infections
		Interventions:	Drug: fosamprenavir; Drug: ritonavir; Drug: saquinavir; Drug: atazanavir

21	Recruiting	Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
		Condition:	HIV Infections
		Interventions:	Drug: atazanavir/ritonavir; Drug: darunavir/ritonavir

22	Completed	HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
		Condition:	HIV-1 Infection
		Intervention:	Drug: fosamprenavir/ritonavir

23	Active, not recruiting	A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
		Condition:	HIV
		Interventions:	Drug: fos-amprenavir calcium, ritonavir; Drug: abacavir/lamivudine as Epzicom

24	Recruiting	A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir
		Condition:	HIV Infections
		Intervention:	Drug: Indinavir/Ritonavir/Fosamprenavir

25	Completed	Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-Resistant HIV
		Condition:	HIV Infections
		Interventions:	Drug: lopinavir/ritonavir; Drug: indinavir sulfate; Drug: tenofovir disoproxil fumarate; Drug: ritonavir; Drug: fosamprenavir

26	Recruiting	Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
		Condition:	HIV Infections
		Interventions:	Drug: Nelfinavir; Drug: Lopinavir/ritonavir; Drug: Ritonavir; Drug: Amprenavir; Drug: Indinavir; Drug: Saquinavir; Drug: Fosamprenavir; Drug: Atazanavir; Drug: Tipranavir

27	Completed	VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-State.
		Conditions:	HIV; Telaprevir; Hepatitis C
		Intervention:	Drug: Telaprevir; Darunavir; Ritonavir; Fosamprenavir

28	Recruiting	A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
		Condition:	Human Immunodeficiency Virus Infections
		Interventions:	Drug: Lexiva + Norvir + Epzicom; Drug: Sustiva + Epzicom

29	Recruiting	Clinical Trial of CNS-Targeted HAART (CIT2)
		Condition:	HIV Infections
		Intervention:	Drug: FDA Approved Antiretroviral Therapy (see list below)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options